Top

The International Journal of Cardiovascular Imaging

Published in:

01-12-2009 | Editorial Comment

Cardiopulmonary exercise testing in thalassemia

Authors: John-Paul Carpenter, Dudley J. Pennell

Published in: The International Journal of Cardiovascular Imaging | Issue 8/2009

Excerpt

In this issue of International Journal of Cardiac Imaging, researchers from the Onassis Cardiac Surgery Centre and Agia Sophia Hospital in Athens report their findings of cardiopulmonary exercise testing (CPET) in relation to cardiovascular magnetic resonance (CMR) in patients with thalassemia major (TM) [1]. In support of previously available evidence, they found raised cardiac iron and low left ventricular ejection fraction in patients with heart failure. In addition, CPET indices (VO₂max, anaerobic threshold (AT), metabolic equivalents (METs) and exercise duration) were not only lower in TM patients with heart failure but were closely correlated with iron loading, measured by CMR T2*. …

Mavrogeni S, Gotsis E, Verganelakis D, Berdoussis E, Dritsas A, Kolovou G, Toulas P, Ladis V (2009) Effect of iron overload on exercise capacity in thalassemic patients with heart failure. Int J Cardiovasc Imaging. doi:10.1007/s10554-009-9491-9

Modell B, Darlison M (2008) Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 86(6):480–487CrossRefPubMed

Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ (2008) Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 10(1):42CrossRefPubMed

Herschko C, Link G, Cabantchik I (1998) Pathophysiology of iron overload. Ann NY Acad Sci 850:191–201CrossRef

Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342:1077–1084CrossRefPubMed

Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Porter J, Walker JM, Pennell DJ (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22:2171–2179CrossRefPubMed

Fitchett DJ, Coltart DJ, Littler WA, Leyland MJ, Trueman T, Gozzard DI, Peters TJ (1980) Cardiac involvement in secondary haemochromatosis: a catheter biopsy study and analysis of myocardium. Cardiovasc Res 14(12):719–724CrossRefPubMed

Wood JC, Otto-Duessel M, Aguilar M, Nick H, Nelson MD, Coates TD, Pollack H, Moats R (2005) Cardiac iron determines cardiac T2*, T2 and T1 in the gerbil model of iron cardiomyopathy. Circulation 112(4):272–280CrossRef

Kirk P, Roughton M, Porter JB, Walker JM, Tanner MA, Patel J, Wu D, Taylor J, Westwood MA, Anderson LJ, Pennell DJ (2009) Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation Oct 2 [Epub ahead of print]

10.

Anderson LJ, Westwood MA, Holden S, Davis B, Prescott E, Wonke B, Porter JB, Walker JM, Pennell DJ (2004) Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol 127:348–355CrossRefPubMed

11.

Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, Roughton M, Assomull R, Nair V, Walker JM, Pennell DJ (2007) A randomized, placebo-controlled, double blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation 115:1876–1884CrossRefPubMed

12.

Pennell DJ, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A, Gotsis ED, Tanner MA, Smith GC, Westwood MA, Wonke B, Galanello R (2006) Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood 107:3738–3744CrossRefPubMed

13.

Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, Pibiri M, Nair SV, Walker JM, Pennell DJ (2008) Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction. J Cardiovasc Magn Reson 10:12CrossRefPubMed

14.

15.

Mavrogeni SI, Gotsis ED, Markussis V, Tsekos N, Politis C, Vretou E, Kremastinos D (1998) T2 relaxation time study of iron overload in b-thalassemia. MAGMA 6(1):7–12CrossRefPubMed

16.

Mavrogeni SI, Markussis V, Kaklamanis L, Tsiapras D, Paraskevaidis I, Karavolias G, Karagiorga M, Douskou M, Cokkinos DV, Kremastinos DT (2005) A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron in patients with beta-thalassemia major. Eur J Haematol 75:241–247CrossRefPubMed

17.

He T, Kirk P, Firmin DN, Lam WM, Chu WC, Au WY, Chan GC, Tan RS, Ng I, Biceroglu S, Aydinok Y, Fogel MA, Cohen AR, Pennell DJ (2008) Multi-center transferability of a breath-hold T2 technique for myocardial iron assessment. J Cardiovasc Magn Reson 10:11CrossRefPubMed

18.

Mavrogeni S, Gotsis ED, Berdousi E, Ladis V, Verganelakis K, Toulas P, Cokkinos DV (2007) Myocardial and hepatic T2* magnetic resonance evaluation in ex-thalassemic patients after bone-marrow transplantation. Int J Cardiovasc Imaging 23(6):739–745CrossRefPubMed

19.

Dimopoulou I, Kremastinos DT, Maris TG, Mavrogeni S, Tzelepis GE (1999) Respiratory function in patients with thalassaemia and iron overload. Eur Respir J 13(3):602–605CrossRefPubMed

20.

Vasileiadis I, Roditis P, Dimopoulos S, Ladis V, Pangalis G, Aessopos A, Nanas S (2009) Impaired oxygen kinetics in beta-thalassaemia major patients. Acta Physiol (Oxf) 196(3):357–363CrossRef

21.

Nanas S, Vasileiadis I, Dimopoulos S, Sakellariou D, Kapsimalakou S, Papazachou O, Tasoulis A, Ladis V, Pangalis G, Aessopos A (2009) New insights into the exercise tolerance of beta-thalassaemia major patients. Scand J Med Sci Sports 19(1):96–102PubMedCrossRef

22.

Albouaini K, Egred M, Alahmar A, Wright DJ (2007) Cardiopulmonary exercise testing and its application. Heart 93:1285–1292PubMed

23.

Yeh MP, Gardner RM, Adams TD, Yanowitz FG, Crapo RO (1983) “Anaerobic threshold”: problems of determination and validation. J Appl Physiol 55(4):1178–1186PubMed

24.

Corra U, Mezzani A, Bosimini E, Giannuzzi P (2004) Cardiopulmonary exercise testing and prognosis in chronic heart failure: a prognosticating algorithm for the individual patient. Chest 126(3):942–950CrossRefPubMed

Title: Cardiopulmonary exercise testing in thalassemia
Authors: John-Paul Carpenter
Dudley J. Pennell
Publication date: 01-12-2009
Publisher: Springer Netherlands
Published in: The International Journal of Cardiovascular Imaging / Issue 8/2009
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI: https://doi.org/10.1007/s10554-009-9537-z

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cardiopulmonary exercise testing in thalassemia

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2009

Determination of right ventricular end systole by cardiovascular magnetic resonance imaging: a standard method of selection

An appearance of “non-compaction” of the right systemic ventricle is common in congenitally corrected transposition of the great arteries

HIV infection and abnormal regional ventricular function

Coronary calcification: Achilles’ heel in the assessment for coronary artery disease in patients with symptomatic angina?

Optimal image reconstruction phase at low and high heart rates in dual-source CT coronary angiography

Early detection of iron overload in the heart: a key role for MRI!

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page